United Biomedical Inc.

COVID vaccines that induce broad polyclonal responses or potently enlist T cells could upstage single-antigen products when it comes to variants

Covaxx licenses COVID vaccine to Aurobindo Aurobindo Pharma Ltd. (NSE:AUROPHARMA; BSE:524804) gained exclusive rights from the Covaxx unit of United Biomedical Inc. to develop and market UB-612 in

FDA approves Y-mAbs’ Danyelza for neuroblastomaShares of Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) were up 17% in after-hours trading Wednesday after FDA granted accelerated approval to Danyelza

The dizzying pace of COVID-19 vaccine readouts over the last three weeks is only going to accelerate over the next five. By the end of the year, three of the four leading vaccines are likely to yield

Emerging Company Profile: after its COVID-19 vaccine, Vaxxinity plans to take on mAbs for chronic diseases with vaccines against the same targets

How AD vaccine UB-311 could be safer than other anti-beta amyloid therapies